{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:47:33Z","timestamp":1793242053996,"version":"4.5.0"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Yeasts have contributed to human and animal health through functional antigen production for vaccine formulations. Some yeast-made vaccines have become a reality for humankind because they have reached commercialization (hepatitis B, HPV, and tick parasitosis). Many other vaccine prototypes are under preclinical and clinical evaluations, hoping for their usage soon. Currently, genomes, genetic modification techniques, and industrial vaccine manufacturing have been successfully developed for\n                    <jats:italic>Saccharomyces cerevisiae<\/jats:italic>\n                    ,\n                    <jats:italic>Komagataella phaffii (formerly Pichia pastoris)<\/jats:italic>\n                    , and\n                    <jats:italic>Hansenula polymorpha<\/jats:italic>\n                    . Moreover, several yeast species are under research as prospects for vaccine production systems, such as\n                    <jats:italic>Kluyveromyces lactis, Yarrowia lipolytica, Schizosaccharomyces pombe, Saccharomyces boulardii<\/jats:italic>\n                    , and\n                    <jats:italic>Komagataella phaffii<\/jats:italic>\n                    . This review was mainly focused on commercial human and animal vaccines, describing and discussing genetic engineering tools, downstream antigen purification processes, GMP according to regulatory issues, and identifying challenges and future directions on the use of yeast as a vaccine production platform to fight against infectious diseases.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1697177","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:37:24Z","timestamp":1763534244000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Yeast vaccine production platform for human and animal infectious diseases"],"prefix":"10.3389","volume":"16","author":[{"given":"Abel","family":"Ramos-Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Monreal-Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Ba\u00f1uelos-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-443-13337-4.00017-3","article-title":"Infectious diseases and its global epidemiology","volume-title":"Nanostructured Drug Delivery Systems in Infectious Disease Treatment","author":"Baral","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.12703\/r\/11-2","article-title":"Emergence of epidemic diseases: zoonoses and other origins","volume":"11","author":"Weiss","year":"2022","journal-title":"Fac Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"100224","DOI":"10.1016\/j.coesh.2020.10.012","article-title":"Aspects of excessive antibiotic consumption and environmental influences correlated with the occurrence of resistance to antimicrobial agents","volume":"19","author":"Bungau","year":"2021","journal-title":"Curr Opin Environ Sci Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1402981111","article-title":"Vaccines, new opportunities for a new society","volume":"111","author":"Rappuoli","year":"2014","journal-title":"Proc Natl Acad Scie"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121490","article-title":"Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities","volume":"9","author":"Ghattas","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12934-022-01929-8","article-title":"Recombinant vaccines in 2022: a perspective from the cell factory","volume":"21","author":"de Pinho Favaro","year":"2022","journal-title":"Microb Cell Fact"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4103\/apjtm.apjtm_854_23","article-title":"Recombinant vaccines: Current updates and future prospects","volume":"17","author":"Kumar","year":"2024","journal-title":"Asian Pac J Trop Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"foz007","DOI":"10.1093\/femsyr\/foz007","article-title":"Yeast-based vaccines: New perspective in vaccine development and application","volume":"19","author":"Kumar","year":"2019","journal-title":"FEMS Yeast Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/298347a0","article-title":"Synthesis and assembly of hepatitis B virus surface antigen particles in yeast","volume":"298","author":"Valenzuela","year":"1982","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/307178a0","article-title":"Human hepatitis B vaccine from recombinant yeast","volume":"307","author":"McAleer","year":"1984","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1567-1364.2011.00769.x","article-title":"Introduction and expression of genes for metabolic engineering applications in Saccharomyces cerevisiae","volume":"12","author":"Da Silva","year":"2012","journal-title":"FEMS Yeast Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2019.00094","article-title":"Advances in using hansenula polymorpha as chassis for recombinant protein production","volume":"7","author":"Manfr\u00e3o-Netto","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00192-2","article-title":"Large-scale production in Pichia pastoris of the recombinant vaccine Gavac\u2122 against cattle tick","volume":"15","author":"Canales","year":"1997","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4017(99)00213-7","article-title":"Evaluation of TickGARDPLUS, a novel vaccine against Boophilus microplus, in lactating Holstein\u2013Friesian cows","volume":"88","author":"Jonsson","year":"2000","journal-title":"Vet Parasitol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.22319\/rmcp.v14i3.6255","article-title":"Prote\u00edna Bm86 y su potencial uso como vacuna contra garrapatas en el ganado bovino. Revisi\u00f3n","volume":"14","author":"Galv\u00e1n Arellano","year":"2023","journal-title":"Rev Mex Cienc Pecu"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1088\/1755-1315\/913\/1\/012099","article-title":"Advantages of yeast-based recombinant protein technology as vaccine products against infectious diseases","volume":"913","author":"Lestari","year":"2021","journal-title":"IOP Conf Ser Earth Environ Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.4.1929","article-title":"Transformation of yeast","volume":"75","author":"Hinnen","year":"1978","journal-title":"Proc Natl Acad Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/275104a0","article-title":"Transformation of yeast by a replicating hybrid plasmid","volume":"275","author":"Beggs","year":"1978","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/jb.153.1.163-168.1983","article-title":"Transformation of intact yeast cells treated with alkali cations","volume":"153","author":"Ito","year":"1983","journal-title":"J Bacteriol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3109\/07388559209069191","article-title":"Strategies for the genetic manipulation of saccharomyces cerevisiae","volume":"12","author":"Tuite","year":"1992","journal-title":"Crit Rev Biotechnol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/yea.3308","article-title":"History of genome editing in yeast","volume":"35","author":"Fraczek","year":"2018","journal-title":"Yeast"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-019-00164-8","article-title":"Yeast expression systems: overview and recent advances","volume":"61","author":"Baghban","year":"2019","journal-title":"Mol Biotechnol"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-61779-770-5_4","volume-title":"Preparation of Saccharomyces cerevisiae Expression Plasmids","author":"Drew","year":"2012"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(92)90454-W","article-title":"Multifunctional yeast high-copy-number shuttle vectors","volume":"110","author":"Christianson","year":"1992","journal-title":"Gene"},{"key":"B25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.copbio.2014.03.005","article-title":"Microbial tolerance engineering toward biochemical production: from lignocellulose to products","volume":"29","author":"Ling","year":"2014","journal-title":"Curr Opin Biotechnol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature11478","article-title":"Microbial engineering for the production of advanced biofuels","volume":"488","author":"Peralta-Yahya","year":"2012","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115605","article-title":"Enabling technologies for in situ biomanufacturing using probiotic yeast","volume":"223","author":"Parker","year":"2025","journal-title":"Adv Drug Delivery Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biortech.2024.131806","article-title":"Engineering and evolution of Yarrowia lipolytica for producing lipids from lignocellulosic hydrolysates","volume":"416","author":"Yook","year":"2025","journal-title":"Bioresour Technol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(95)00037-7","article-title":"Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds","volume":"156","author":"Mumberg","year":"1995","journal-title":"Gene"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1600187","article-title":"Transforming non-conventional yeasts into key players in biotechnology: advances in synthetic biology applications","volume":"16","author":"Moon","year":"2025","journal-title":"Front Microbiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.5.12.3376-3385.1985","article-title":"Pichia pastoris as a host system for transformations","volume":"5","author":"Cregg","year":"1985","journal-title":"Mol Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot102160","article-title":"Expression of cloned genes in pichia pastoris using the methanol-inducible promoter AOX1","volume":"2021","author":"Kielkopf","year":"2021","journal-title":"Cold Spring Harb Protoc"},{"key":"B33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.mie.2021.07.004","article-title":"Expression of proteins in Pichia pastoris","volume":"660","author":"Mastropietro","year":"2021","journal-title":"Methods Enzymology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13568-020-00972-131","article-title":"Orthologous promoters from related methylotrophic yeasts surpass expression of endogenous promoters of Pichia pastoris","volume":"10","author":"Vogl","year":"2020","journal-title":"AMB Express"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-099953-1.00010-7","article-title":"The recovery and purification of fermentation products","author":"Stanbury","year":"2017","journal-title":"Princ Ferment Technol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-9821.1000185","article-title":"Demonstrating \u03b2-glucan clearance in CHO- and yeast-produced monoclonal antibodies during downstream purification processes","volume":"4","author":"Wang","year":"2014","journal-title":"J Bioprocess Biotech"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-816109-8.00026-X","article-title":"Downstream processing of biotechnology products","volume-title":"Basic Biotech Bioproc Bioentrepreneursh","author":"Bedade","year":"2023"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-444-63357-6.00007-9","article-title":"Downstream processing","volume-title":"Biochemical Engineering and Biotechnology","author":"Najafpour","year":"2015"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1201\/9781315164953-15","article-title":"Downstream processing","author":"Gottschalk","year":"2019","journal-title":"Filtr Purif Biopharm Ind"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-91167-2.00007-1","article-title":"Advances in downstream processing techniques","author":"Sinha","year":"2022","journal-title":"Curr Dev Biotechnol Bioeng"},{"key":"B41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0015-1882(06)70950-8","article-title":"Depth filtration: Cell clarification of bioreactor offloads","volume":"43","author":"Prashad","year":"2006","journal-title":"Filtr Sep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/10_2017_12","article-title":"Downstream processing technologies\/capturing and final purification","volume":"165","author":"Singh","year":"2017","journal-title":"In Adv Biochem Eng Biotechnol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.24275\/rmiq\/Bio725","article-title":"Fed-batch cultivation and operational conditions for the production of a recombinant anti-amoebic vaccine in Pichia pastoris system","volume":"19","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2019","journal-title":"Rev Mex Ing Quim"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/07388551.2018.1554620","article-title":"Fed-batch high-cell-density fermentation strategies for Pichia pastoris growth and production","volume":"39","author":"Liu","year":"2019","journal-title":"Crit Rev Biotechnol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1042\/EBC20200138","article-title":"Established tools and emerging trends for the production of recombinant proteins and metabolites in Pichia pastoris","volume":"65","author":"De","year":"2021","journal-title":"Essays Biochem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00085","article-title":"Playing catch-up with Escherichia coli: using yeast to increase success rates in recombinant protein production experiments","volume":"5","author":"Bill","year":"2014","journal-title":"Front Microbiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12353","article-title":"Recombinant protein subunit vaccine synthesis in microbes: a role for yeast","volume":"67","author":"Bill","year":"2015","journal-title":"Jou Pha Pha"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11101602","article-title":"Large-scale purification and characterization of recombinant receptor-binding domain (RBD) of SARS-coV-2 spike protein expressed in yeast","volume":"11","author":"Nagar","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/01496395.2015.1135949","article-title":"Two-step purification strategy for enhanced recovery of recombinant hepatitis B surface antigen from Pichia pastoris","volume":"51","author":"Tam","year":"2016","journal-title":"Sep Sci Technol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2859-10-48","article-title":"Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen","volume":"10","author":"L\u00fcnsdorf","year":"2011","journal-title":"Microb Cell Fact"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s10529-022-03298-z","article-title":"High-yield production in Escherichia coli and convenient purification of a candidate vaccine against SARS-CoV-2","volume":"44","author":"Maltoni","year":"2022","journal-title":"Biotechnol Lett"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-004-1559-9","article-title":"Secretory and extracellular production of recombinant proteins using Escherichia coli","volume":"64","author":"Choi","year":"2004","journal-title":"Appl Microbiol Biotechnol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/mps8040089","article-title":"Expression of recombinant hirudin in bacteria and yeast: A comparative approach","volume":"8","author":"Wang","year":"2025","journal-title":"Methods Protoc"},{"key":"B54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/B978-1-4557-0090-5.00019-7","article-title":"Vaccine manufacturing","author":"Gomez","year":"2013","journal-title":"Vaccines"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-91146-7.00004-4","article-title":"GMP manufacture and quality control","author":"Ashfield","year":"2022","journal-title":"Vaccinol Methods Vaccine Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1021905","article-title":"Current GMP standards for the production of vaccines and antibodies: An overview","volume":"10","author":"Covarrubias","year":"2022","journal-title":"Front Public Health"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126186","article-title":"The life cycle of vaccines evaluated by the European Medicines Agency","volume":"42","author":"Gr\u00e4f","year":"2024","journal-title":"Vaccine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/1750-3841.12813","article-title":"Effect of initial PH on growth characteristics and fermentation properties of saccharomyces cerevisiae","volume":"80","author":"Liu","year":"2015","journal-title":"J Food Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0507-2","article-title":"Viral contamination in biologic manufacture and implications for emerging therapies","volume":"38","author":"Barone","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156830","article-title":"When recombinant proteins go wrong: The hidden pitfall of recombinant protein contamination","volume":"186","author":"Svraka","year":"2025","journal-title":"Cytokine"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2017.08.014","article-title":"Major findings and recent advances in virus\u2013like particle (VLP)-based vaccines","volume":"34","author":"Mohsen","year":"2017","journal-title":"Semin Immunol"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1002\/9781118971147","volume-title":"ICH quality guidelines: An implementation guide","author":"Teasdale","year":"2017"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/B978-0-323-35761-6.00079-1","article-title":"Regulation and testing of vaccines","author":"Gruber","year":"2018","journal-title":"Plotkin\u2019s Vaccines"},{"key":"B64","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/B978-0-323-35761-6.00080-8","article-title":"Regulation of vaccines in europe","volume-title":"Plotkin\u2019s Vaccines","author":"Ehmann","year":"2018"},{"key":"B65","unstructured":"Guidelines on clinical evaluation of vaccines: regulatory expectations\n          \n          \n          World Healt Organization Technical Report\n          \n          2017"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(22)00171","article-title":"Developing an effective and sustainable national immunisation programme in China: issues and challenges","volume":"7","author":"Chen","year":"2022","journal-title":"Lancet Public Health"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-023-01136-6","article-title":"Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward","volume":"12","author":"Zhao","year":"2023","journal-title":"Infect Dis Poverty"},{"key":"B68","unstructured":"Malaria vaccines (RTS,S and R21)\n          \n          \n          \n          2025"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/1567-1364.12023","article-title":"Repression vs. activation of MOX, FMD, MPP1 and MAL1 promoters by sugars in Hansenula polymorpha : the outcome depends on cell\u2019s ability to phosphorylate sugar","volume":"13","author":"Suppi","year":"2013","journal-title":"FEMS Yeast Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-017-8357-7","article-title":"Agrobacterium tumefaciens-mediated transformation of oleaginous yeast Lipomyces species","volume":"101","author":"Dai","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12951-021-00806-7","article-title":"Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers","volume":"19","author":"Nooraei","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1567-1364.2010.00665.x","article-title":"Vaccines based on whole recombinant Saccharomyces cerevisiae cells","volume":"10","author":"Ardiani","year":"2010","journal-title":"FEMS Yeast Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4131324","article-title":"Yeast surface-displayed H5N1 avian influenza vaccines","volume":"2016","author":"Lei","year":"2016","journal-title":"J Immunol Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1901545","article-title":"SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice","volume":"17","author":"Pollet","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.(2024).114538","article-title":"Exploring yeast glucans for vaccine enhancement: Sustainable strategies for overcoming adjuvant challenges in a SARS-CoV-2 model","volume":"205","author":"Azevedo-Silva","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020479","article-title":"Yeast-based virus-like particles as an emerging platform for vaccine development and delivery","volume":"11","author":"Srivastava","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1150412","article-title":"Yeast oral vaccines against infectious diseases","volume":"14","author":"Austriaco","year":"2023","journal-title":"Front Microbiol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1141101","article-title":"Development of a rapid reverse genetics system for feline coronavirus based on TAR cloning in yeast","volume":"14","author":"Cao","year":"2023","journal-title":"Front Microbiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.809711","article-title":"A novel whole yeast-based subunit oral vaccine against eimeria tenella in chickens","volume":"13","author":"Soutter","year":"2022","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2020.03.013","article-title":"Oral vaccination using Artemia coated with recombinant Saccharomyces cerevisiae expressing cyprinid herpesvirus-3 envelope antigen induces protective immunity in common carp (Cyprinus carpio var","volume":"130","author":"Ma","year":"2020","journal-title":"Jian) larvae. Res Vet Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2020.01.034","article-title":"Protective immunity against CyHV-3 infection via different prime-boost vaccination regimens using CyHV-3 ORF131-based DNA\/protein subunit vaccines in carp Cyprinus carpio var","volume":"98","author":"Liu","year":"2020","journal-title":"Jian. Fish Shellfish Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932722","article-title":"Gut mucosal immune responses and protective efficacy of oral yeast Cyprinid herpesvirus 2 (CyHV-2) vaccine in Carassius auratus gibelio","volume":"13","author":"Dong","year":"2022","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s13071-016-1862-1","article-title":"A recombinant multi-antigen vaccine formulation containing Babesia bovis merozoite surface antigens MSA-2a1, MSA-2b and MSA-2c elicits invasion-inhibitory antibodies and IFN-\u03b3 producing cells","volume":"9","author":"Gimenez","year":"2016","journal-title":"Parasit Vectors"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674484","article-title":"Development of a potential yeast-based vaccine platform for theileria parva infection in cattle","volume":"12","author":"Goh","year":"2021","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.003","article-title":"Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo","volume":"33","author":"Patterson","year":"2015","journal-title":"Vaccine"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-020-00278-3","article-title":"Porcine immunoglobulin fc fused P30\/P54 protein of african swine fever virus displaying on surface of S. cerevisiae elicit strong antibody production in swine","volume":"36","author":"Chen","year":"2021","journal-title":"Virol Sin"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1371\/journal.pmed.0020295","article-title":"Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs","volume":"2","author":"Loukas","year":"2005","journal-title":"PLoS Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104094","article-title":"The cloning of the virus envelope glycoprotein F of canine distemper virus expressed in Pichia pastoris","volume":"142","author":"Tizzano","year":"2020","journal-title":"Microb Pathog"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182000001487","article-title":"Commercialisation of a recombinant vaccine against Boophilus microplus","volume":"110","author":"Willadsen","year":"1995","journal-title":"Parasitology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.livsci.2016.02.005","article-title":"High impact and effectiveness of Gavac\u2122 vaccine in the national program for control of bovine ticks Rhipicephalus microplus in Venezuela","volume":"187","author":"Suarez","year":"2016","journal-title":"Livest Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9091030","article-title":"A review of Australian tick vaccine research","volume":"9","author":"Tabor","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63660-7.00017-6","article-title":"Recombinant veterinary vaccines","author":"Dellagostin","year":"2017","journal-title":"Curr Dev Biotechnol Bioeng"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.654289","article-title":"Novel vaccine technologies in veterinary medicine: A herald to human medicine vaccines","volume":"8","author":"Aida","year":"2021","journal-title":"Front Vet Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00172","article-title":"Recombinant protein expression in Escherichia coli: advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front Microbiol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-022-01917-y","article-title":"Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity","volume":"21","author":"Zhang","year":"2022","journal-title":"Microb Cell Fact"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2010.06.009","article-title":"Post-translational modifications of protein biopharmaceuticals","volume":"15","author":"Walsh","year":"2010","journal-title":"Drug Discov Today"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/cpps.47","article-title":"Overview of the baculovirus expression system","volume":"91","author":"Chambers","year":"2018","journal-title":"Curr Protoc Protein Sci"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.994743","article-title":"Genetic engineering of baculovirus-insect cell system to improve protein production","volume":"10","author":"Hong","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2085565","article-title":"The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing","volume":"21","author":"Trombetta","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"B100","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2217\/fmb.14.104","article-title":"Engineering yeast for producing human glycoproteins: where are we now","volume":"10","author":"Laukens","year":"2015","journal-title":"Future Microbiol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/jof8111179","article-title":"Non-mammalian eukaryotic expression systems yeast and fungi in the production of biologics","volume":"8","author":"Garvey","year":"2022","journal-title":"J Fungi"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1017\/S1466252307001193","article-title":"A ten-year review of commercial vaccine performance for control of tick infestations on cattle","volume":"8","author":"de la Fuente","year":"2007","journal-title":"Anim Health Res Rev"},{"key":"B103","first-page":"35","article-title":"Stability, safety and protective immunity of Gavac\u00ae vaccine subjected to heat stress","volume":"35","author":"Vargas-Hernandez","year":"2018","journal-title":"Biotecnol Apl"},{"key":"B104","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12863-019-0754-8","article-title":"Genetic diversity of Bm86 sequences in Rhipicephalus (Boophilus) microplus ticks from Mexico: analysis of haplotype distribution patterns","volume":"20","author":"Mart\u00ednez-Arzate","year":"2019","journal-title":"BMC Genet"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1017\/S003118202400043X","article-title":"Evolution of tick vaccinology","volume":"151","author":"de la Fuente","year":"2024","journal-title":"Parasitology"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101185","article-title":"From bench to field: A guide to formulating and evaluating anti-tick vaccines delving beyond efficacy to effectiveness","volume":"9","author":"Ndawula","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2007.09.001","article-title":"Glycosylation engineering in yeast: the advent of fully humanized yeast","volume":"18","author":"Hamilton","year":"2007","journal-title":"Curr Opin Biotechnol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2006.09.033","article-title":"Immune response in mice and cattle after immunization with a Boophilus microplus DNA vaccine containing bm86 gene","volume":"144","author":"Ruiz","year":"2007","journal-title":"Vet Parasitol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1087","article-title":"The humanization of N-glycosylation pathways in yeast","volume":"3","author":"Wildt","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-017-8101-3","article-title":"Abolishment of N-glycan mannosylphosphorylation in glyco-engineered Saccharomyces cerevisiae by double disruption of MNN4 and MNN14 genes","volume":"101","author":"Kim","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1128\/AEM.02817-12","article-title":"Frey AD. A combined system for engineering glycosylation efficiency and glycan structure in saccharomyces cerevisiae","volume":"79","author":"Parsaie Nasab","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.4161\/hv.27464","article-title":"Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate","volume":"10","author":"Chen","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"B113","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1021\/acssynbio.9b00372","article-title":"Host-informed expression of CRISPR guide RNA for genomic engineering in komagataella phaffii","volume":"9","author":"Dalvie","year":"2020","journal-title":"ACS Synth Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/lam.12695","article-title":"Yeast as an expression system for producing virus-like particles: what factors do we need to consider","volume":"64","author":"Kim","year":"2017","journal-title":"Lett Appl Microbiol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41426-017-0005-x","article-title":"Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice","volume":"7","author":"Zhang","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e64595","DOI":"10.1371\/journal.pone.0064595","article-title":"Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies","volume":"8","author":"Mani","year":"2013","journal-title":"PLoS One"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.08.054","article-title":"Protective immunity of a Pichia pastoris expressed recombinant iridovirus major capsid protein in the Chinese giant salamander, Andrias davidianus","volume":"33","author":"Zhou","year":"2015","journal-title":"Vaccine"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00141","article-title":"Expression, purification and characterization of the hepatitis E virus like-particles in the pichia pastoris","volume":"11","author":"Gupta","year":"2020","journal-title":"Front Microbiol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201400427","article-title":"Enveloped virus-like particles as vaccines against pathogenic arboviruses","volume":"10","author":"Pijlman","year":"2015","journal-title":"Biotechnol J"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.082281199","article-title":"HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae","volume":"99","author":"Sakuragi","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.062","article-title":"Generation of a parvovirus B19 vaccine candidate","volume":"31","author":"Chandramouli","year":"2013","journal-title":"Vaccine"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.1412.12027","article-title":"Production of recombinant human papillomavirus type 52 L1 protein in hansenula polymorpha formed virus-like particles","volume":"25","author":"Liu","year":"2015","journal-title":"J Microbiol Biotechnol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(91)90193-F","article-title":"Production of hepatitis B virion-like particles in yeast","volume":"106","author":"Kouichi","year":"1991","journal-title":"Gene"},{"key":"B124","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0168-1656(01)00254-1","article-title":"Expression of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris using the GAP promoter","volume":"88","author":"Vassileva","year":"2001","journal-title":"J Biotechnol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s10529-006-9242-0","article-title":"Expression of hepatitis B surface antigen in Saccharomyces cerevisiae utilizing glyceraldeyhyde-3-phosphate dehydrogenase promoter of Pichia pastoris","volume":"29","author":"Vellanki","year":"2007","journal-title":"Biotechnol Lett"},{"key":"B126","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12934-017-0768-8","article-title":"A novel bi-directional promoter system allows tunable recombinant protein production in Pichia pastoris","volume":"16","author":"Rajamanickam","year":"2017","journal-title":"Microb Cell Fact"},{"key":"B127","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-4939-9024-5_3","article-title":"Pichia pastoris promoters","volume":"1923","author":"T\u00fcrkano\u011flu \u00d6z\u00e7elik","year":"2019","journal-title":"Methods Mol Biol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1128\/IAI.66.1.59-64.1998","article-title":"Saccharomyces cerevisiae -Secreted Fusion Proteins Pfs25 and Pfs28 Elicit Potent Plasmodium falciparum Transmission-Blocking Antibodies in Mice","volume":"66","author":"Gozar","year":"1998","journal-title":"Infect Immun"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-12-70","article-title":"Enhanced cell disruption strategy in the release of recombinant hepatitis B surface antigen from Pichia pastoris using response surface methodology","volume":"12","author":"Tam","year":"2012","journal-title":"BMC Biotechnol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/bab.1701","article-title":"High recovery of intracellular recombinant HBsAg from Pichia pastoris via continuous pulsed laser cell disruption system optimized by response surface methodology","volume":"66","author":"Gazor","year":"2019","journal-title":"Biotechnol Appl Biochem"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1080\/10826068.2018.1466153","article-title":"Improving the recovery of clarification process of recombinant hepatitis B surface antigen in large-scale by optimizing adsorption-desorption parameters on Aerosil-380","volume":"48","author":"Hosseini","year":"2018","journal-title":"Prep Biochem Biotechnol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1080\/10826068.2018.1550658","article-title":"Integration of size-exclusion chromatography and ultracentrifugation for purification of recombinant hepatitis B surface antigen: An alternative method for immunoaffinity chromatography","volume":"49","author":"Yousefipour","year":"2019","journal-title":"Prep Biochem Biotechnol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2019.03.009","article-title":"A novel application of ion exchange chromatography in recombinant hepatitis B vaccine downstream processing: Improving recombinant HBsAg homogeneity by removing associated aggregates","volume":"1113","author":"Kimia","year":"2019","journal-title":"J Chromatogr B"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35124","article-title":"DOE-based process optimization for development of efficient methods for purification of recombinant hepatitis B surface antigen from Pichia pastoris feedstock using Capto adhere resin","volume":"10","author":"Moazami Goodarzi","year":"2024","journal-title":"Heliyon"},{"key":"B135","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pep.2017.08.011","article-title":"Enhancing recovery of recombinant hepatitis B surface antigen in lab-scale and large-scale anion-exchange chromatography by optimizing the conductivity of buffers","volume":"141","author":"Mojarrad Moghanloo","year":"2018","journal-title":"Protein Expr Purif"},{"key":"B136","doi-asserted-by":"publisher","first-page":"10745","DOI":"10.1038\/s41598-023-37614-y","article-title":"Determining buffer conditions for downstream processing of VLP-based recombinant hepatitis B surface antigen using multimodal resins in bind-elute and flow-through purification modes","volume":"13","author":"Goodarzi","year":"2023","journal-title":"Sci Rep"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1080\/10826068.2018.1487854","article-title":"Large-scale purification of recombinant hepatitis B surface antigen from Pichia pastoris with non-affinity chromatographic methods as a substitute to immunoaffinity chromatography","volume":"48","author":"Hosseini","year":"2018","journal-title":"Prep Biochem Biotechnol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e0267206","DOI":"10.1371\/journal.pone.0267206","article-title":"Progress in affinity ligand-functionalized bacterial magnetosome nanoparticles for bio-immunomagnetic separation of HBsAg protein","volume":"17","author":"Hatami Giklou Jajan","year":"2022","journal-title":"PLoS One"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.4142\/jvs.2014.15.2.199","article-title":"Recombinant Kluyveromyces lactis expressing highly pathogenic porcine reproductive and respiratory syndrome virus GP5 elicits mucosal and cell-mediated immune responses in mice","volume":"15","author":"Zhao","year":"2014","journal-title":"J Vet Sci"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.094","article-title":"Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme","volume":"37","author":"Gebauer","year":"2019","journal-title":"Vaccine"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12030433","article-title":"Co-Immunization Efficacy of Recombinant Antigens against Rhipicephalus microplus and Hyalomma anatolicumTick Infestations","volume":"12","author":"Parthasarathi","year":"2023","journal-title":"Pathogens"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-017-7218-5","article-title":"Development of recombinant Yarrowia lipolytica producing virus-like particles of a fish nervous necrosis virus","volume":"55","author":"Luu","year":"2017","journal-title":"J Microbiol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.virusres.2005.02.001","article-title":"A human papillomavirus type 16 vaccine by oral delivery of L1 protein","volume":"110","author":"Sasagawa","year":"2005","journal-title":"Virus Res"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1007\/s10529-009-0047-9","article-title":"Integrity of a recombinant hemagglutinin protein of an avian influenza virus","volume":"31","author":"Wu","year":"2009","journal-title":"Biotechnol Lett"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.07.141","article-title":"Uptake of various yeast genera by antigen-presenting cells and influence of subcellular antigen localization on the activation of ovalbumin-specific CD8 T lymphocytes","volume":"29","author":"Bazan","year":"2011","journal-title":"Vaccine"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00723","article-title":"Oral administration of recombinant saccharomyces boulardii expressing ovalbumin-CPE fusion protein induces antibody response in mice","volume":"9","author":"Bagherpour","year":"2018","journal-title":"Front Microbiol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2024.2399589","article-title":"Analytical methods for evaluating the immunogenicity of recombinant rabies virus glycoprotein expressed in the yeast komagataella phaffii","volume":"53","author":"Askri","year":"2024","journal-title":"Immunol Invest"},{"key":"B148","doi-asserted-by":"publisher","first-page":"e13996","DOI":"10.1111\/jfd.13996","article-title":"Immersion immunization with recombinant Saccharomyces cerevisiae displaying ORF25 induced protective immunity against cyprinid herpesvirus 2","volume":"47","author":"Yang","year":"2024","journal-title":"J Fish Dis"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2024.110099","article-title":"A vaccine combining ORF132 and ORF25 expressed by Saccharomyces cerevisiae induces protective immunity in Carassius auratus gibelio against CyHV-2","volume":"157","author":"Liang","year":"2025","journal-title":"Fish Shellfish Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-025-01409-5","article-title":"An engineered SARS-coV-2 S1 glycoprotein produced in pichia pastoris as a candidate vaccine antigen","author":"Majidi","year":"2025","journal-title":"Mol Biotechnol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12091077","article-title":"Vaccine potency and structure of yeast-produced polio type 2 stabilized virus-like particles","volume":"12","author":"Hong","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126385","article-title":"Saccharomyces cerevisiae as a platform for vaccination against bovine mastitis","volume":"42","author":"Danzelle","year":"2024","journal-title":"Vaccine"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107894","article-title":"Enhancing Mycobacterium tuberculosis-Ag85B immunogenicity by fusing with human Fc\u03b31 (Ag85B:hFc\u03b31)","volume":"207","author":"Bahrami","year":"2025","journal-title":"Microb Pathog"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1128\/aem.01817-24","article-title":"Recombinant Saccharomyces cerevisiae EBY100\/pYD1-FaeG: a candidate for an oral subunit vaccine against F4+ ETEC infection","volume":"91","author":"Hu","year":"2025","journal-title":"Appl Environ Microbiol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2025.101831","article-title":"Expression, purification, and immunogenicity study of human papillomavirus type 52 virus-like particles produced in Hansenula polymorpha","volume":"90","author":"Chairunnisa","year":"2025","journal-title":"Biologicals"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2024.09.009","article-title":"VEGF165b mutant can be used as a protein carrier to form a chimeric tumor vaccine with Mucin1 peptide to elicit an anti-tumor response","volume":"175","author":"Liang","year":"2024","journal-title":"Mol Immunol"},{"key":"B157","unstructured":"VAXELIS\n          \n          \n          \n          2023"},{"key":"B158","unstructured":"TWINRIX\n          \n          \n          \n          2023"},{"key":"B159","unstructured":"Recombivax HB\n          \n          \n          \n          2019"},{"key":"B160","unstructured":"ENGERIX-B\n          \n          \n          \n          2023"},{"key":"B161","unstructured":"HEPLISAV-B\n          \n          \n          \n          2024"},{"key":"B162","unstructured":"GARDASIL\n          \n          \n          \n          2025"},{"key":"B163","unstructured":"GARDASIL 9\n          \n          \n          \n          2025"},{"key":"B164","unstructured":"Hexyon\n          \n          \n          \n          2025"},{"key":"B165","unstructured":"Fendrix\n          \n          \n          European Medicines Agency\n          \n          2023"},{"key":"B166","unstructured":"Hexacima\n          \n          \n          European Medicines Agency\n          \n          2025"},{"key":"B167","unstructured":"HBVaxPro\n          \n          \n          European Medicines Agency\n          \n          2025"},{"key":"B168","unstructured":"Vaxelis\n          \n          \n          European Medicines Agency\n          \n          2024"},{"key":"B169","unstructured":"Mosquirix - opinion on medicine for use outside EU\n          \n          \n          European Medicines Agency\n          \n          2025"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taad140","article-title":"R21\/Matrix-M\u2122 malaria vaccine: a new tool to achieve WHO\u2019s goal to eliminate malaria in 30 countries by 2030","volume":"30","author":"Genton","year":"2023","journal-title":"J Travel Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1697177\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:37:29Z","timestamp":1763534249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1697177\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":170,"alternative-id":["10.3389\/fimmu.2025.1697177"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1697177","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"article-number":"1697177"}}